TRPC3 as a Target of Novel Therapeutic Interventions
AbstractTRPC3 is one of the classical members of the mammalian transient receptor potential (TRP) superfamily of ion channels. TRPC3 is a molecule with intriguing sensory features including the direct recognition of and activation by diacylglycerols (DAG). Although TRPC3 channels are ubiquitously expressed, they appear to control functions of the cardiovascular system and the brain in a highly specific manner. Moreover, a role of TRPC3 in immunity, cancer, and tissue remodeling has been proposed, generating much interest in TRPC3 as a target for pharmacological intervention. Advances in the understanding of molecular architecture and structure-function relations of TRPC3 have been the foundations for novel therapeutic approaches, such as photopharmacology and optochemical genetics of TRPC3. This review provides an account of advances in therapeutic targeting of TRPC3 channels. View Full-Text
Share & Cite This Article
Tiapko, O.; Groschner, K. TRPC3 as a Target of Novel Therapeutic Interventions. Cells 2018, 7, 83.
Tiapko O, Groschner K. TRPC3 as a Target of Novel Therapeutic Interventions. Cells. 2018; 7(7):83.Chicago/Turabian Style
Tiapko, Oleksandra; Groschner, Klaus. 2018. "TRPC3 as a Target of Novel Therapeutic Interventions." Cells 7, no. 7: 83.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.